Antibody Oxidation’s Hidden Handedness Comes Into View - Report - MDSpire
Advertisement
Antibody Oxidation’s Hidden Handedness Comes Into View
Integrated NMR and LC-MS analysis distinguishes elusive stereochemical forms of methionine oxidation in IgG1 Fc regions, offering a sharper tool for biologic drug quality control
Clinical Report: Antibody Oxidation’s Hidden Handedness Comes Into View
Overview
A novel analytical strategy has revealed the stereochemical diversity of methionine oxidation in therapeutic antibodies, specifically distinguishing R and S forms in IgG1 antibodies. This advancement may enhance stability testing and manufacturing control for antibody drugs.
Background
Understanding antibody stability is critical in therapeutic applications, as oxidation of methionine residues can significantly impact receptor interactions and in vivo persistence. Traditional methods have struggled to analyze the stereochemical variations of these modifications, which are essential for optimizing antibody efficacy and safety. The new approach utilizing NMR and LC-MS offers a more precise characterization of these subtle changes.
Data Highlights
No numerical data available in the source material.
Key Findings
The study identified R and S stereoisomers of methionine sulfoxide in the Fc region of IgG1 antibodies.
Oxidation of Met252 occurs more readily than Met428 due to its solvent-exposed nature.
NMR spectroscopy revealed multiple oxidation-dependent signals for methionine residues.
Selective enzymatic reduction with methionine sulfoxide reductase A confirmed the stereochemistry of oxidized products.
The findings suggest that stereochemical analysis can improve stability testing and manufacturing control for antibody therapeutics.
Clinical Implications
The ability to distinguish between stereoisomers of methionine sulfoxide in antibodies can enhance the understanding of how these modifications affect antibody function and stability. This knowledge is crucial for the development and quality control of therapeutic antibodies, potentially leading to improved patient outcomes.
Conclusion
The integration of advanced analytical techniques provides a deeper understanding of antibody oxidation, which is vital for ensuring the quality and efficacy of therapeutic antibodies.